Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas systems have revolutionized genetic engineering, offering a precise and efficient platform for genome editing.  This review summarizes the mechanism of action of CRISPR-Cas systems, focusing primarily on the widely utilized type II system employing Cas9.  The simplicity and programmability of CRISPR-Cas9, enabled by guide RNA targeting, allows for targeted gene disruption, insertion, and replacement with remarkable precision compared to previous technologies. This has significantly advanced gene therapy research, with ongoing clinical trials demonstrating its potential in treating various genetic disorders.  Furthermore, CRISPRâ€™s application extends beyond therapeutic contexts, encompassing agricultural improvements via targeted gene modification in crops and livestock, and fundamental biological research through functional genomic studies.  However, challenges remain, including off-target effects, delivery limitations, and ethical concerns surrounding germline editing.  Addressing these challenges is crucial for the responsible and widespread implementation of CRISPR technology, maximizing its transformative potential while mitigating potential risks. Ongoing research focuses on improving targeting specificity, developing novel delivery methods, and establishing robust safety protocols to fully realize the promise of CRISPR-Cas systems in diverse fields.